Live news related to BIOMERIEUX stock (FR0013280286): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The latest financial news on BIOMERIEUX mainly cover M&A activity et analyst notes. The stock trades at €90,70 on Euronext Paris, up 0,61% at the last update. This page lists the articles published on BIOMERIEUX stock to track the share price, company announcements and any item likely to influence market perception.
The in vitro diagnostics manufacturer briefly exceeded a technical threshold at the start of trading before retreating below this level. The stock rem…
The in vitro diagnostics manufacturer extends a rebound underway for several weeks. An upgrade from a major brokerage firm, released this morning, acc…
bioMérieux announced on October 19, 2026 that the World Health Organization (WHO) had granted emergency use listing (EUL) to its Biofire Global Fever …
The in vitro diagnostics manufacturer is having a well-oriented session in a Paris market that is also advancing. The share extends a rebound of sever…
The in vitro diagnostics manufacturer is standing out sharply from a slightly rising Paris stock exchange. The stock is extending a rebound initiated …
The in vitro diagnostics manufacturer enjoys a well-oriented session, while the Paris exchange loses ground. After a rebound underway for several week…
The shares of the in vitro diagnostics manufacturer are trading significantly higher in this back-to-school session, bringing its gains to more than t…
bioMérieux stands out as one of the rare equities resisting the general decline in European markets this Thursday, pushing its price beyond a technica…
The in vitro diagnostics manufacturer unveiled a point-of-care testing platform intended for emergency services, one year after the acquisition of Nor…
The in vitro diagnostics specialist has achieved a regulatory milestone by obtaining, for two of its syndromic respiratory tests, the most demanding c…
